ResMed’s board members honored

Tuesday, November 20, 2018

SAN DIEGO – Two members of ResMed’s board of directors have been named to WomenInc. Magazine’s “2018 Most Influential Corporate Directors,” a list of women executives, influencers and achievers contributing leadership to corporate boards. Carol Burt has served on ResMed’s board since November 2013 and is chairwoman of its Audit Committee. She is principal of Burt-Hilliard Investments. Karen Drexler has served on the board since November 2017 and is director of the Compensation Committee. She is CEO of Sandstone Diagnostics. “We’re honored to be listed among so many successful, innovative women driving businesses and the products and services they provide,” Burt and Drexler said in a joint statement. “Diversity at the board level and in the workplace contributes unique perspectives that help support the companies and communities they serve.”